Amphastar Pharmaceuticals Inc (AMPH) Price

Amphastar Generic Approval Challenges Eli Lilly Forteo

Amphastar Pharmaceuticals secured FDA approval for its generic teriparatide injection, a direct competitor to Eli Lilly's osteoporosis drug, Forteo. This approval introduces new competition and potential price pressure in the established osteoporosis treatment market.